{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:33:29Z","timestamp":1790354009129,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung stereotactic body radiotherapy (SBRT) requires highly reproducible workflow execution because of steep dose gradients, respiratory motion, and narrow treatment margins. This study evaluated the workflow effectiveness and process-safety impact of an FMEA-guided quality-improvement workflow for lung SBRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center historical-control study included 128 patients treated with lung SBRT. Sixty-three patients treated under conventional quality-control procedures served as the control group, and 65 patients managed after implementation of an FMEA-guided quality-improvement workflow served as the FMEA-guided group. The workflow included risk identification, targeted corrective measures, respiratory coaching, dual verification, immobilization optimization, and enhanced equipment quality control. RPN changes were analyzed using the Wilcoxon signed-rank test. CBCT-derived setup deviations were assessed using patient-level median absolute couch correction values and fraction-level linear mixed-effects models. Workflow-related adverse events were compared using Fisher\u2019s exact test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven high-risk failure modes were identified. The overall median residual RPN was lower than the initial RPN [39.0 (IQR, 26.0\u201346.5) vs 177.5 (IQR, 165.0\u2013209.0);\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.003]. The setup-error analysis included 374 CBCT registrations from 63 control patients and 388 registrations from 65 patients in the FMEA-guided group. Patient-level median absolute couch correction values were smaller in the FMEA-guided group, and fraction-level mixed-effects models confirmed significantly smaller deviations across all six translational and rotational dimensions. Workflow-related adverse events decreased from 11.11% to 3.08%, but the difference was not statistically significant (RR\u00a0=\u00a00.277, 95% CI, 0.060\u20131.282;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.093).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Implementation of an FMEA-guided quality-improvement workflow was associated with reduced residual RPN scores and smaller CBCT-derived setup deviations in lung SBRT. Workflow-related adverse events decreased numerically but did not reach statistical significance. These findings support the value of proactive, closed-loop workflow risk management, while further prospective multicenter validation is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1860664","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:50:03Z","timestamp":1784695803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Implementation of an FMEA-guided quality-improvement workflow is associated with improved setup accuracy in lung stereotactic body radiotherapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Zunhao","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Ganzhou Cancer Hospital","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ganzhou Cancer Hospital","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ganzhou Cancer Hospital","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ganzhou Cancer Hospital","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Ganzhou Cancer Hospital","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.0043","article-title":"NCCN Guidelines\u00ae Insights: Non-small cell lung cancer, version 7.2025","volume":"23","author":"Riely","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2025.103997","article-title":"Population-based outcomes of single-fraction stereotactic ablative radiotherapy for early stage non-small cell lung cancer","volume":"50","author":"Atrchian","year":"2026","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-025-01324-6","article-title":"Immunotherapy-boosted stereotactic ablative radiotherapy in inoperable early-stage non-small cell lung cancer","volume":"26","author":"Lian","year":"2025","journal-title":"Curr Treat Options Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-992","article-title":"Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis","volume":"13","author":"Yang","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01077","article-title":"Common error pathways in CyberKnife\u2122 radiation therapy","volume":"10","author":"Mullins","year":"2020","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(23)67220-2","article-title":"PO-2305 a clinical audit of patient safety in an Irish radiotherapy department","volume":"182","author":"O'Sullivan","year":"2023","journal-title":"Radiotherapy Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109494","article-title":"Prioritizing clinical trial quality assurance for photons and protons: a failure modes and effects analysis (FMEA) comparison","volume":"182","author":"Taylor","year":"2023","journal-title":"Radiother Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1118\/1.4947547","article-title":"The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management","volume":"43","author":"Huq","year":"2016","journal-title":"Med Phys"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2018.02.006","article-title":"Stereotactic ablative radiotherapy uncertainties: Delineation, setup and motion","volume":"28","author":"Yang","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.14624","article-title":"AAPM-RSS medical physics practice guideline 9.b: SRS-SBRT","volume":"26","author":"Cirino","year":"2025","journal-title":"J Appl Clin Med Phys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/mp.14992","article-title":"AAPM Task Group 198 report: An implementation guide for TG 142 quality assurance of medical accelerators","volume":"48","author":"Letourneau","year":"2021","journal-title":"Med Phys"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110657","article-title":"Aiming for patient safety indicators in radiation oncology - Results from a systematic literature review as part of the PaSaGeRO study","volume":"203","author":"Baehr","year":"2025","journal-title":"Radiother Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13014-021-01945-9","article-title":"Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience","volume":"16","author":"Garcia Sch\u00fcler","year":"2021","journal-title":"Radiat Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03539-9","article-title":"Clinical effects of re-evaluating a lung SBRT failure mode and effects analysis in a radiotherapy department","volume":"26","author":"Benavente","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.09.019","article-title":"Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy","volume":"83","author":"Perks","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.12663","article-title":"The irregular breathing effect on target volume and coverage for lung stereotactic body radiotherapy","volume":"20","author":"Pan","year":"2019","journal-title":"J Appl Clin Med Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S202119","article-title":"Prevalence and risk factors of anxiety and depression in Chinese patients with lung cancer: a cross-sectional study","volume":"11","author":"Yan","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.220353","article-title":"Investigating different computed tomography techniques for internal target volume definition","volume":"13","author":"Yoganathan","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211073380","article-title":"Deep learning-based internal target volume (ITV) prediction using cone-beam CT images in lung stereotactic body radiotherapy","volume":"21","author":"Li","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tlcr.2018.09.25","article-title":"Optimizing immobilization, margins, and imaging for lung stereotactic body radiation therapy","volume":"8","author":"Molitoris","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/COC.0000000000001224","article-title":"ACR-ARS practice parameter for the performance of stereotactic body radiation therapy","volume":"49","author":"Chao","year":"2026","journal-title":"Am J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/acm2.12852","article-title":"Use of surface-guided radiation therapy in combination with IGRT for setup and intrafraction motion monitoring during stereotactic body radiation therapy treatments of the lung and abdomen","volume":"21","author":"Heinzerling","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2025.101731","article-title":"Fuzzy analytical hierarchy process-based risk priority number approach in failure modes and effects analysis for magnetic resonance imaging-guided high-dose-rate brachytherapy for gynecologic cancer","volume":"10","author":"Chang","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jmrs.42","article-title":"The effect of image-guided radiation therapy on the margin between the clinical target volume and planning target volume in lung cancer","volume":"61","author":"Liang","year":"2014","journal-title":"J Med Radiat Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13014-020-01496-5","article-title":"ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT","volume":"15","author":"Bellec","year":"2020","journal-title":"Radiat Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1860664\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:50:06Z","timestamp":1784695806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1860664\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":27,"alternative-id":["10.3389\/fonc.2026.1860664"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1860664","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1860664"}}